As of 2026-03-26, the Relative Valuation of Quest Diagnostics Inc (DGX) is 195.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 196.08 USD, the upside of Quest Diagnostics Inc based on Relative Valuation is -0.5%.
The range of the Relative Valuation is 180.32 - 207.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 23.0x | 21.5x |
| Forward P/E multiples | 18.6x - 20.3x | 20.2x |
| Fair Price | 180.32 - 207.84 | 195.06 |
| Upside | -8.0% - 6.0% | -0.5% |
| Date | P/E |
| 2026-03-24 | 21.72 |
| 2026-03-23 | 21.66 |
| 2026-03-20 | 21.63 |
| 2026-03-19 | 21.50 |
| 2026-03-18 | 21.62 |
| 2026-03-17 | 22.00 |
| 2026-03-16 | 22.03 |
| 2026-03-13 | 22.12 |
| 2026-03-12 | 22.25 |
| 2026-03-11 | 22.21 |
| 2026-03-10 | 22.25 |
| 2026-03-09 | 22.33 |
| 2026-03-06 | 22.06 |
| 2026-03-05 | 22.59 |
| 2026-03-04 | 23.09 |
| 2026-03-03 | 23.08 |
| 2026-03-02 | 23.29 |
| 2026-02-27 | 23.47 |
| 2026-02-26 | 23.38 |
| 2026-02-25 | 23.02 |
| 2026-02-24 | 23.21 |
| 2026-02-23 | 22.97 |
| 2026-02-20 | 22.42 |
| 2026-02-19 | 22.42 |
| 2026-02-18 | 22.64 |
| 2026-02-17 | 22.76 |
| 2026-02-13 | 22.91 |
| 2026-02-12 | 22.91 |
| 2026-02-11 | 23.18 |
| 2026-02-10 | 22.74 |
| 2026-02-09 | 21.18 |
| 2026-02-06 | 21.12 |
| 2026-02-05 | 21.30 |
| 2026-02-04 | 20.96 |
| 2026-02-03 | 20.51 |
| 2026-02-02 | 20.49 |
| 2026-01-30 | 20.71 |
| 2026-01-29 | 20.20 |
| 2026-01-28 | 20.24 |
| 2026-01-27 | 20.41 |
| 2026-01-26 | 20.22 |
| 2026-01-23 | 20.05 |
| 2026-01-22 | 20.18 |
| 2026-01-21 | 20.45 |
| 2026-01-20 | 20.93 |
| 2026-01-16 | 20.99 |
| 2026-01-15 | 21.07 |
| 2026-01-14 | 20.69 |
| 2026-01-13 | 19.93 |
| 2026-01-12 | 19.49 |